These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 7538751
21. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. Endl J, Otto H, Jung G, Dreisbusch B, Donie F, Stahl P, Elbracht R, Schmitz G, Meinl E, Hummel M, Ziegler AG, Wank R, Schendel DJ. J Clin Invest; 1997 May 15; 99(10):2405-15. PubMed ID: 9153283 [Abstract] [Full Text] [Related]
25. Is there MHC Class II restriction of the response to MHC Class I in transplant patients? Papassavas AC, Barnardo MC, Bunce M, Welsh KI. Transplantation; 2002 Feb 27; 73(4):642-51. PubMed ID: 11889447 [Abstract] [Full Text] [Related]
26. Structure of peptides associated with class I and class II MHC molecules. Engelhard VH. Annu Rev Immunol; 1994 Feb 27; 12():181-207. PubMed ID: 7516668 [Abstract] [Full Text] [Related]
31. The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire. Chao CC, Sytwu HK, Chen EL, Toma J, McDevitt HO. Proc Natl Acad Sci U S A; 1999 Aug 03; 96(16):9299-304. PubMed ID: 10430937 [Abstract] [Full Text] [Related]
33. Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences. Meister GE, Roberts CG, Berzofsky JA, De Groot AS. Vaccine; 1995 Apr 03; 13(6):581-91. PubMed ID: 7483779 [Abstract] [Full Text] [Related]
34. Peptide binding motifs for MHC class I and II molecules. Biddison WE, Martin R. Curr Protoc Immunol; 2001 May 03; Appendix 1():Appendix 1I. PubMed ID: 18432645 [Abstract] [Full Text] [Related]
35. Estimating design space available for polyepitopes through consideration of major histocompatibility complex binding motifs. Lee Y, Ferrari G, Lee SC. Biomed Microdevices; 2010 Apr 03; 12(2):207-22. PubMed ID: 20033850 [Abstract] [Full Text] [Related]
36. Prediction of potential cytotoxic T lymphocyte epitopes of bovine herpesvirus 1 based on allele-specific peptide motifs and proteolytic cleavage specificities. Hegde NR, Srikumaran S. Virus Genes; 1996 Apr 03; 13(2):121-33. PubMed ID: 8972566 [Abstract] [Full Text] [Related]
37. Identification of MHC Ligands and Establishing MHC Class I Peptide Motifs. Ghosh M, Di Marco M, Stevanović S. Methods Mol Biol; 2019 Apr 03; 1988():137-147. PubMed ID: 31147938 [Abstract] [Full Text] [Related]
38. The use of bovine MHC class I allele-specific peptide motifs and proteolytic cleavage specificities for the prediction of potential cytotoxic T lymphocyte epitopes of bovine viral diarrhea virus. Hegde NR, Srikumaran S. Virus Genes; 1997 Apr 03; 14(2):111-21. PubMed ID: 9237350 [Abstract] [Full Text] [Related]
39. Binding motifs predict major histocompatibility complex class II-restricted epitopes in the Sendai virus M protein. Cole GA, Tao T, Hogg TL, Ryan KW, Woodland DL. J Virol; 1995 Dec 03; 69(12):8057-60. PubMed ID: 7494321 [Abstract] [Full Text] [Related]
40. Establishing MHC class I peptide motifs. Trautwein N, Stevanović S. Methods Mol Biol; 2013 Dec 03; 960():159-168. PubMed ID: 23329486 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]